St. Jude Dual-Chamber ICD Follow-Ons To Photon On Track, Starks Says
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical expects at least a two-point market share gain in 2001 by entering the more rapidly growing dual-chamber segment of the U.S. implantable cardioverter defibrillator market, in the wake of FDA's Oct. 30 approval of the Photon dual-chamber device.